Summary
A study was made of the effect of the bone marrow transplantation in rats of the Wistar line with sarcoma M-1 treated with toxic ThioTEPA doses.
The bone marrow transplantation contributed to the survival of rats after a single dose of thioTEPA—12.5 mg/kg — or following its repeated administration in a total course dose of 27.3 mg/kg body weight. Tumor regression was noted after a repeated administration of the preparation, whereas single doses caused but temporary inhibition of the tumor growth.
Similar content being viewed by others
Literature Cited
N. S. Artem'eva and L. M. Farutina, Byull. éksper. biol. 1, p. 98 (1962).
V. A. Chernov, A. A. Grushina, and Zh. F. Zakharova, Vopr. onkol., 9, p. 350 (1959).
H. L. Lochte, Jr., S. Kasakura, and M. Karetzky et al., Blood (1963), v. 31, p. 424.
A. C. Sartorelli and G. A. LePage, Proc. Am. Ass. Cancer Res. (1957), v. 2, No. 3, p. 246.
R. Talbot and L. A. Elson, Nature (1958), v. 181, p. 684.
Tran Ba Loc, G. Mathé, and J. Bernard, Rev. franc. Et. clin. biol. (1958), v. 3, p. 472.
J. K. Weston, R. E. Maxwell and M. Lee et al., Fed. Proc. (1957), v. 16, No. 1, Pt. 1, p. 377.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sukhin, G.M. Transplantation of bone marrow in rats with sarcoma M-1 after the use of toxic doses of thioTEPA. Bull Exp Biol Med 59, 81–84 (1965). https://doi.org/10.1007/BF00782073
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00782073